SOURCE: Industrial Info Resources

July 22, 2010 05:30 ET

Biomed Realty Trust Facilitates Isis Pharmaceuticals in Making Cents of Antisense Technology, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwire - July 22, 2010) -  Researched by Industrial Information Resources (Sugar Land, Texas) -- Biomed Realty Trust Incorporated (NYSE:BMR) (San Diego, California) has commenced construction of the future home of Isis Pharmaceuticals Incorporated's (NASDAQ:ISIS) (Carlsbad, California) principal research and development (R&D) operations. The new R&D space will allow Isis to consolidate most of its operations under one roof, creating a synergy that will enable Isis to expand the company's proprietary antisense technology.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=163434, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR) is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. IIR's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. For more information send inquiries to pharmabiogroup@industrialinfo.com or visit us at www.industrialinfo.com.

Follow us on: Facebook - Twitter - LinkedIn - Vimeo

Contact Information

  • Contact:
    Joe Govreau
    713-783-5147